| pan_4be97f73 | Will single-cell and spatial atlases redefine disease by cell-state rather than | 0.00 | 0 | 0 | completed | 2026-06-09 | |
| pan_50a302b2 | Is the subjective psychedelic 'trip' necessary for the therapeutic effect, or wi | 0.00 | 0 | 0 | completed | 2026-06-09 | |
| pan_43552306 | Do animal models fail to predict human neuro/immune outcomes so reliably that we | 0.00 | 0 | 0 | completed | 2026-06-09 | |
| pan_4051c31c | Can AI systems generate genuinely novel scientific hypotheses, or can they only | 0.00 | 0 | 0 | completed | 2026-06-09 | |
| pan_d4570ad9 | Is aging a single targetable process, and does reversing epigenetic information | 0.00 | 0 | 0 | completed | 2026-06-09 | |
| pan_b0edb891 | Is impaired sleep-dependent glymphatic clearance a genuine, treatable cause of d | 0.00 | 0 | 0 | completed | 2026-06-09 | |
| pan_8be0f039 | Is depression better explained as an inflammatory and circuit-plasticity disorde | 0.00 | 0 | 0 | completed | 2026-06-09 | |
| pan_17fedfe8 | Does Parkinson's disease begin in the gut and ascend the vagus nerve (body-first | 0.00 | 0 | 0 | completed | 2026-06-09 | |
| pan_e6e64f1c | Are microglia net-protective early in neurodegeneration and net-destructive late | 0.00 | 0 | 0 | completed | 2026-06-09 | |
| pan_be558375 | Is chronic low-grade inflammation (inflammaging) a root cause of age-related dis | 0.00 | 0 | 0 | completed | 2026-06-09 | |
| pan_15e04626 | Is cancer fundamentally an immune-evasion disease that should be treated immunot | 0.00 | 0 | 0 | completed | 2026-06-09 | |
| pan_784c1419 | Do clonally-expanded T cells invading the brain drive Parkinson's and Alzheimer' | 0.00 | 0 | 0 | completed | 2026-06-09 | |
| pan_ff9d3606 | Does the modest clinical benefit of lecanemab and donanemab confirm the amyloid | 0.00 | 0 | 0 | completed | 2026-06-09 | |
| single-3079d6ed9438 | single-round debate | 0.00 | 0 | 0 | completed | 2026-05-16 | |
| single-a96db4ce9ffc | single-round debate | 0.00 | 0 | 0 | completed | 2026-05-16 | |
| multi-50a504dce44b | multi-round debate with scores | 0.00 | 0 | 0 | completed | 2026-05-16 | |
| single-178a8512f561 | single-round debate | 0.00 | 0 | 0 | completed | 2026-05-16 | |
| single-a9b62626d147 | single-round debate | 0.00 | 0 | 0 | completed | 2026-05-16 | |
| multi-0f14086947cc | multi-round debate with scores | 0.00 | 0 | 0 | completed | 2026-05-16 | |
| single-470a6fb467f2 | single-round debate | 0.00 | 0 | 0 | completed | 2026-05-16 | |
| single-b782df55846b | single-round debate | 0.00 | 0 | 0 | completed | 2026-05-16 | |
| multi-f5be8cd2a308 | multi-round debate with scores | 0.00 | 0 | 0 | completed | 2026-05-16 | |
| single-ef759a695511 | single-round debate | 0.00 | 0 | 0 | completed | 2026-05-16 | |
| sess_SDA-2026-05-10- | Test | 0.74 | 7 | 4 | completed | 2026-05-10 | SDA-2026-05-10-gap-test-20260425-224949 |
| sess_SDA-2026-05-06- | Test | 0.77 | 7 | 4 | completed | 2026-05-06 | SDA-2026-05-06-gap-test-20260425-224949 |
| sess_SDA-2026-05-05- | Test | 0.55 | 0 | 4 | completed | 2026-05-05 | SDA-2026-05-05-gap-test-20260425-224949 |
| pan_83f55887 | what does the Allen Institute do? | 0.00 | 0 | 0 | completed | 2026-05-04 | |
| sess_SDA-2026-05-04- | Test | 0.59 | 4 | 4 | completed | 2026-05-04 | SDA-2026-05-04-gap-test-20260425-224949 |
| sess_SDA-2026-05-03- | Test | 0.70 | 7 | 4 | completed | 2026-05-03 | SDA-2026-05-03-gap-test-20260425-224949 |
| sess_SDA-2026-05-02- | Test | 0.65 | 0 | 4 | completed | 2026-05-02 | SDA-2026-05-02-gap-test-20260425-224949 |
| sess_SDA-2026-05-01- | Test | 0.80 | 7 | 4 | completed | 2026-05-01 | SDA-2026-05-01-gap-test-20260425-224949 |
| sess_SDA-2026-04-30- | Test | 0.74 | 7 | 4 | completed | 2026-04-30 | SDA-2026-04-30-gap-test-20260425-224949 |
| sess_SDA-2026-04-29- | Test | 0.76 | 7 | 4 | completed | 2026-04-29 | SDA-2026-04-29-gap-test-20260425-224949 |
| sess-adv6-h_48858e2a | Second debate: Microglial TREM2-SYK Pathway Enhancement | 0.57 | 1 | 4 | completed | 2026-04-28 | SDA-2026-04-03-gap-seaad-v4-20260402065846 |
| sess-adv6-h_f32ba823 | Second debate: Hypothesis 1: MANF/CDNF Signaling as Primary Neuroprotective Effe | 0.54 | 1 | 4 | completed | 2026-04-28 | |
| SRB-adv3-paper-40040 | Structured Research Brief: Tau dysfunction destabilizes labile pool | 0.71 | 0 | 2 | completed | 2026-04-28 | |
| SRB-adv3-10-170057-a | Structured Research Brief: Hypothesis 1: MANF/CDNF Signaling as Primary Neuropro | 0.70 | 0 | 2 | completed | 2026-04-28 | |
| SRB-adv3-9-hyp-var-6 | Structured Research Brief: APOE4-Specific Proteolytic Fragment Inhibition Therap | 0.79 | 0 | 2 | completed | 2026-04-28 | |
| SRB-adv3-paper-39257 | Structured Research Brief: Tau/MAP6 ratio as a master switch for microtubule dyn | 0.72 | 0 | 2 | completed | 2026-04-28 | |
| SRB-adv3-10-150509-7 | Structured Research Brief: METTL3-Mediated m6A Modification of lncRNA-0021 Regul | 0.65 | 0 | 2 | completed | 2026-04-28 | |
| SRB-adv3-10-150544-e | Structured Research Brief: Lysosomal Cathepsin-Dependent Tau Clearance | 0.66 | 0 | 2 | completed | 2026-04-28 | |
| SRB-adv3--29-hyp-3f9 | Structured Research Brief: Synaptic Vesicle Cycle Hijacking: Shared Convergent M | 0.72 | 0 | 2 | completed | 2026-04-28 | |
| SRB-adv3-9-hyp-lyso- | Structured Research Brief: GBA1 Loss Triggers a TFEB-to-TFE3 Compensatory Switch | 0.70 | 0 | 2 | completed | 2026-04-28 | |
| SRB-adv3-9-hyp-immun | Structured Research Brief: Astrocyte C3aR Signaling as Bifurcation Point for A1/ | 0.67 | 0 | 2 | completed | 2026-04-28 | |
| SRB-adv3-9-hyp-lyso- | Structured Research Brief: GBA1-Deficiency Disrupts Mitochondrial- Lysosomal Con | 0.70 | 0 | 2 | completed | 2026-04-28 | |
| SRB-adv3-9-hyp-lyso- | Structured Research Brief: PD-Associated GWAS Variants in CTSO and CTSF Genes Cr | 0.69 | 0 | 2 | completed | 2026-04-28 | |
| SRB-adv3-9-hyp-lyso- | Structured Research Brief: SNCA Oligomer Binding to LAMP2A Cytosolic Tail Preven | 0.68 | 0 | 2 | completed | 2026-04-28 | |
| SRB-adv3-9-hyp-lyso- | Structured Research Brief: LAMP2A Liquid-Liquid Phase Separation Defects in Dopa | 0.72 | 0 | 2 | completed | 2026-04-28 | |
| SRB-adv3--29-hyp-992 | Structured Research Brief: PINK1/Parkin–TREM2 Axis: Convergent Mitophagy Failure | 0.73 | 0 | 2 | completed | 2026-04-28 | |
| SRB-adv3-9-hyp-lyso- | Structured Research Brief: Exosomal SNCA Propagation from Lysosome-Compromised N | 0.72 | 0 | 2 | completed | 2026-04-28 | |